Effect of preoperative chemotherapy on postoperative liver regeneration following hepatic resection as estimated by liver volume

World Journal of Surgical Oncology

Volumn 11, Issue , 2013, Pages

  Takeda, Daiki ^a   Nitta, Hiroyuki ^a   Takahara, Takeshi ^a   Hasegawa, Yasushi ^a   Itou, Naoko ^a   Wakabayashi, Go ^a  

^a IWATE MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BEVACIZUMAB; CETUXIMAB; FLUOROURACIL; FOLINIC ACID; IRINOTECAN; OXALIPLATIN;

ADULT; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER PATIENT; CLINICAL ARTICLE; COLORECTAL CANCER; COLORECTAL LIVER METASTASIS; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; KLEINER SCORE; LIVER; LIVER METASTASIS; LIVER REGENERATION; LIVER RESECTION; LIVER TRANSPLANTATION; LIVER VENOOCCLUSIVE DISEASE; LIVER WEIGHT; LIVING DONOR; MALE; NONALCOHOLIC FATTY LIVER; POSTOPERATIVE PERIOD; PREOPERATIVE CARE; SCORING SYSTEM; SURGICAL ANATOMY;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COLORECTAL NEOPLASMS; COMBINED MODALITY THERAPY; FATTY LIVER; FEMALE; FOLLOW-UP STUDIES; HEPATECTOMY; HEPATIC VENO-OCCLUSIVE DISEASE; HUMANS; LIVER; LIVER NEOPLASMS; LIVER REGENERATION; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; NEOPLASM STAGING; POSTOPERATIVE PERIOD; PREOPERATIVE CARE; PROGNOSIS; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84874806112     PISSN: None     EISSN: 14777819     Source Type: Journal    
DOI: 10.1186/1477-7819-11-65     Document Type: Article

References (27)

1. Van Cutsem E, Nordlinger B, Adam R. Towards a pan-European consensus on the treatment of patients with colorectal liver metastases. Eur J Cancer 2006 Sep, 42(14):2212-2221.
2. Minagawa M, Makuuchi M, Torzilli G. Extension of the frontiers of surgical indications in the treatment of liver metastases from colorectal cancer. Ann Surg 2000 Apr, 231(4):487-499.
3. Adam R, Delvart V, Pascal G. Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival. Ann Surg 2004, 240(4):644-657. discussion 657-8, 1356466, 15383792.
4. Folprecht G, Grothey A, Alberts S. Neoadjuvant treatment of unresectable colorectal liver metastases: correlation between tumour response and resection rates. Ann Oncol 2005 Aug, 16(8):1311-1319.
5. Charnsangavej C, Clary B, Fong Y. Selection of patients for resection of hepatic colorectal metastases: expert consensus statement. Ann Surg Oncol 2006 Oct, 13(10):1261-1268.
6. Tanaka K, Shimada H, Ueda M. Long-term characteristics of 5-year survivors after liver resection for colorectal metastases. Ann Surg Oncol 2007 Apr, 14(4):1336-1346.
7. Sauer R, Becker H, Hohenberger W. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 2004 Oct 21, 351(17):1731-1740.
8. Vauthey JN, Pawlik TM, Ribero D. Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases. J Clin Oncol 2006 May 1, 24(13):2065-2072.
9. Fernandez FG, Ritter J, Goodwin JW. Effect of steatohepatitis associated with irinotecan or oxaliplatin pretreatment on resectability of hepatic colorectal metastases. J Am Coll Surg 2005 Jun, 200(6):845-853.
10. Karoui M, Penna C, Amin-Hashem M. Influence of preoperative chemotherapy on the risk of major hepatectomy for colorectal liver metastases. Ann Surg 2006 Jan, 243(1):1-7.
11. Brouquet A, Benoist S, Julie C. Risk factors for chemotherapy-associated liver injuries: A multivariate analysis of a group of 146 patients with colorectal metastases. Surgery 2009 Apr, 145(4):362-371.
12. Benoist S, Brouquet A, Penna C. Complete response of colorectal liver metastases after chemotherapy: does it mean cure?. J Clin Oncol 2006 Aug 20, 24(24):3939-3945.
13. Bilchik AJ, Poston G, Curley SA. Neoadjuvant chemotherapy for metastatic colon cancer: a cautionary note. J Clin Oncol 2005 Dec 20, 23(36):9073-9078.
14. Rubbia-Brandt L, Audard V, Sartoretti P. Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer. Ann Oncol 2004 Mar, 15(3):460-466.
15. Miyagawa S, Makuuchi M, Kawasaki S. Criteria for safe hepatic resection. Am J Surg 1995 Jun, 169(6):589-594.
16. Kubota K, Makuuchi M, Kusaka K. Measurement of liver volume and hepatic functional reserve as a guide to decision-making in resectional surgery for hepatic tumors. Hepatology 1997 Nov, 26(5):1176-1181.
17. Imamura H, Shimada R, Kubota M. Preoperative portal vein embolization: an audit of 84 patients. Hepatology 1999 Apr, 29(4):1099-1105.
18. Kleiner DE, Brunt EM, Van Natta M. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 2005 Jun, 41(6):1313-1321.
19. Scoggins CR, Campbell ML, Landry CS. Preoperative chemotherapy does not increase morbidity or mortality of hepatic resection for colorectal cancer metastases. Ann Surg Oncol 2009 Jan, 16(1):35-41.
20. Komori H, Beppu T, Baba Y. Histological liver injury and surgical outcome after FOLFOX followed by a hepatectomy for colorectal liver metastases in Japanese patients. Int J Clin Oncol 2010 Jun, 15(3):263-270.
21. McCormack L, Petrowsky H, Jochum W. Hepatic steatosis is a risk factor for postoperative complications after major hepatectomy: a matched case-control study. Ann Surg 2007 Jun, 245(6):923-930.
22. Nakano H, Oussoultzoglou E, Rosso E. Sinusoidal injury increases morbidity after major hepatectomy in patients with colorectal liver metastases receiving preoperative chemotherapy. Ann Surg 2008 Jan, 247(1):118-124.
23. Spelt L, Hermansson L, Tingstedt B. Influence of preoperative chemotherapy on the intraoperative and postoperative course of liver resection for colorectal cancer metastases. World J Surg 2012 Jan, 36(1):157-163.
24. Lehmann K, Rickenbacher A, Weber A. Chemotherapy before liver resection of colorectal metastases: friend or foe?. Ann Surg 2012 Feb, 255(2):237-247.
25. Kampfenkel T, Tischoff I, Bonhag H. [Chemotherapy-associated steatohepatitis in patients with colorectal cancer and surgery on hepatic metastasis: clinical validation of a histopathological scoring system and preoperative risk assessment]. Z Gastroenterol 2011, 49(10):1407-1411. 10.1055/s-0031-1281749, 21964894.
26. Welsh FK, Tilney HS, Tekkis PP. Safe liver resection following chemotherapy for colorectal metastases is a matter of timing. Br J Cancer 2007 Apr 10, 96(7):1037-1042.
27. Ono Y, Kawachi S, Hayashida T. The influence of donor age on liver regeneration and hepatic progenitor cell populations. Surgery 2011 Aug, 150(2):154-161.